GEMCITABINE 100 mg/mL

Gemcitabine 100 mg/mL is an intravenous solution used in cancer treatment. This multi-dose injection is manufactured by Accord Healthcare Inc. in the USA.

Gemcitabine is primarily used in the treatment of various types of cancer. It is often administered intravenously to target cancer cells and inhibit their growth. The specific uses of gemcitabine can vary depending on the type and stage of cancer, as determined by a healthcare provider.

Common effects of gemcitabine may include fatigue, nausea, and a decreased appetite. Some individuals may also experience hair loss or changes in their blood cell counts. These effects can vary in severity and duration among different patients.

Gemcitabine should be handled with care, as it is a potent medication. It is important to follow proper safety protocols when administering this injection to avoid contamination or accidental exposure. Patients should be monitored regularly for any adverse reactions.

Gemcitabine may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with gemcitabine.